<format type="yaml">{report_id: string, report_date: date, patient_details: {patient_id: string, age_at_reaction: number optional, gender: string, relevant_history: list[string]}, suspected_drugs: list[{drug_name: string, drug_class: string optional, dosage: string, route_of_administration: string, start_date: date, end_date: date optional, indication_for_use: string}], adverse_reactions: list[{symptom_name: string, onset_date: date, severity: string, outcome: string, intervention_required: boolean, intervention_details: string optional}], causality_assessment: {naranjo_score: number optional, assessment_conclusion: string, dechallenge_rechallenge: string}, reporting_facility: string, reporter_type: string, notes: string optional}</format> <data>PHARMACOVIGILANCE CASE REPORT - CONFIDENTIAL
Report Identifier: ADR-2024-386
Date of Submission: 2024-08-29

This report was submitted by a Patient from Moran, Pratt and Long Medical Center concerning patient ANON-PX-8094. The subject is a 64-year-old male with a significant medical history including migraines, atrial fibrillation. The facility's standard operating procedure for ADR reporting was followed, and all patient data has been anonymized. The patient chart was reviewed for comorbidities. 

Current medication review revealed the following suspected agent(s): Lisinopril administered via the Subcutaneous route at a dosage of 6mg, initiated on 2024-08-20 for Hypertension with the course ongoing.

On approximately 2024-08-21, the patient began to manifest an adverse event. The primary symptoms noted in the clinical log were Pruritus, Nausea. The Pruritus was classified as Life-threatening in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Fatal'. The Nausea was classified as Life-threatening in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Fatal'. 

CAUSALITY ASSESSMENT:
An evaluation of causality was performed. A Naranjo score of 1 was calculated, The assessment concluded the relationship was 'Possible'. Dechallenge/Rechallenge status was noted as: 'Not applicable'. The on-site pharmacist concurred with the assessment during a routine case review. 

Reporter's Narrative Summary: Article word race picture increase institution story picture. Someone pretty begin thousand recent.</data>
report_id: ADR-2024-386
report_date: '2024-08-29'
patient_details:
  patient_id: ANON-PX-8094
  gender: Male
  relevant_history:
  - migraines
  - atrial fibrillation
  age_at_reaction: 64
suspected_drugs:
- drug_name: Lisinopril
  dosage: 6mg
  route_of_administration: Subcutaneous
  start_date: '2024-08-20'
  indication_for_use: Hypertension
adverse_reactions:
- symptom_name: Pruritus
  onset_date: '2024-08-21'
  severity: Life-threatening
  outcome: Fatal
  intervention_required: false
- symptom_name: Nausea
  onset_date: '2024-08-21'
  severity: Life-threatening
  outcome: Fatal
  intervention_required: false
causality_assessment:
  assessment_conclusion: Possible
  dechallenge_rechallenge: Not applicable
  naranjo_score: 1
reporting_facility: Moran, Pratt and Long Medical Center
reporter_type: Patient
notes: Article word race picture increase institution story picture. Someone pretty
  begin thousand recent.
